Litcius/Paper detail

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, Ping Li, Peng Liang, Htay Htay Han, Joshua G. Liang, Ralf Clemens

2021The Lancet282 citationsDOIOpen Access PDF

Topics & Concepts

ReactogenicityMedicinePlaceboImmunogenicityAdjuvantImmunologyVaccinationAntibodyInternal medicineClinical trialPathologyAlternative medicineSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesImmunotherapy and Immune Responses
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial | Litcius